Delivery Order SPE2DB22D1106-SPE2DB25FEXF9
- Not listed
- The Defense Logistics Agency awarded a $86,365.07 delivery order to AmerisourceBergen Drug Corp for the supply of Prevnar 20 syringes (0.5mL) under a firm fixed-price contract type. The award, announced on July 16, 2025, with an ultimate completion date of July 17, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the prime contractor for this medical supply delivery order, which will be performed at the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,703.93 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 syringes (0.5ML) with an ultimate completion date of September 12, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in...
- The Defense Logistics Agency awarded a $10,990.43 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Prevnar 20 vaccine in 0.5 milliliter syringes. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's established capability to meet...
- The Defense Logistics Agency awarded a $10,447.21 delivery order to AmerisourceBergen Drug Corp for Prevnar 20 syringes (0.5ML) under a firm fixed-price contract. The award was issued on September 19, 2025, with an ultimate completion date of September 22, 2025. This delivery order was competitively awarded without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $28,274.55 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 syringes (0.5 mL) with an ultimate completion date of August 28, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract represents a continuation of AmerisourceBergen's role as a critical federal medical procurement vendor, particularly...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Prevnar 20 syringes. This firm fixed-price delivery order, valued at $27,774.09, represents a competitive award with no set-aside designation and is scheduled for completion by August 28, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a $3,267.56 delivery order to AmerisourceBergen Drug Corp for Prevnar 20 vaccine in 0.5ML syringes, with an ultimate completion date of July 11, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order valued at $26,253.17 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 syringes (0.5mL) under a firm fixed price contract. The order was competitively awarded without set-aside provisions and is scheduled for completion by May 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $3,267.56 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 syringes (0.5ML) on April 28, 2025, with an ultimate completion date of April 29, 2025. This non-competitive delivery order represents a firm fixed price transaction for pharmaceutical supplies to support federal medical procurement needs. The contract is being performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $71,304.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 syringes (0.5mL) with an ultimate completion date of June 4, 2025. This non-set-aside competitive award leverages AmerisourceBergen's extensive pharmaceutical distribution capabilities to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEXF9Delivery Order
The Defense Logistics Agency awarded a $54,273.05 delivery order to AmerisourceBergen Drug Corp for the supply of Prevnar 20 syringes (0.5ML) with a completion date of July 11, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply military healthcare programs worldwide with a broad range of pharmaceutical products, vaccines, and medical supplies. The company's role as a critical federal medical procurement vendor positions it to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contracting mechanisms aligned with DLA's strategic pharmaceutical supply chain initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $54.3k | 7/10/25 |